Iteos Therapeutics Inc expected to post a loss of 41 cents a share - Earnings Preview

iTeos Therapeutics

11/08/2021 22:50

* Iteos Therapeutics Inc  ITOS.OQ   ITOS.O  is expected to show
a rise in quarterly revenue when it reports results on August
12. 
* The Cambridge, Massachusetts-based company is expected to
report revenue of $3.906 million, according to the mean estimate
from 5 analysts, based on Refinitiv data.  
​* Refinitiv's mean analyst estimate for Iteos Therapeutics Inc
is for a loss of 41 cents per share. For the same quarter last
year, the company reported a loss of $29.49 per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Iteos
Therapeutics Inc is $50​, about 50% above​ its last closing
price of $25.02. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.48       -0.48      -0.39     Beat    18.4
 Dec. 31 2020              -0.42      -0.43     Missed  -1.8
 Sep. 30 2020  -0.36       -0.36      -0.48     Missed  -31.9​
 Jun. 30 2020  -0.47       -0.47      -29.49    Missed  -6,208
 ​​            ​                                        ​
                                                        ​
 This summary was machine generated August 11 at 21:50 GMT.  All
figures in US dollars unless otherwise stated